Abstract
BackgroundTreatment of high grade serous ovarian cancer (HGSOC) after debulking and chemotherapy remains challenging. This phase 1 trial (NCT04739527) evaluates the use of a cell-based cancer vaccine, vididencel, to prevent...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have